NL194780B - Oraal therapeutisch systeem voor toediening van een anticonvulsivum. - Google Patents

Oraal therapeutisch systeem voor toediening van een anticonvulsivum.

Info

Publication number
NL194780B
NL194780B NL8701857A NL8701857A NL194780B NL 194780 B NL194780 B NL 194780B NL 8701857 A NL8701857 A NL 8701857A NL 8701857 A NL8701857 A NL 8701857A NL 194780 B NL194780 B NL 194780B
Authority
NL
Netherlands
Prior art keywords
anticonvulsant
administration
therapeutic system
oral therapeutic
oral
Prior art date
Application number
NL8701857A
Other languages
English (en)
Other versions
NL194780C (nl
NL8701857A (nl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NL8701857A publication Critical patent/NL8701857A/nl
Publication of NL194780B publication Critical patent/NL194780B/nl
Application granted granted Critical
Publication of NL194780C publication Critical patent/NL194780C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NL8701857A 1986-08-07 1987-08-06 Oraal therapeutisch systeem voor toediening van een anticonvulsivum. NL194780C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH317286 1986-08-07
CH3172/86A CH668187A5 (de) 1986-08-07 1986-08-07 Therapeutisches system mit systemischer wirkung.

Publications (3)

Publication Number Publication Date
NL8701857A NL8701857A (nl) 1988-03-01
NL194780B true NL194780B (nl) 2002-11-01
NL194780C NL194780C (nl) 2003-03-04

Family

ID=4250176

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8701857A NL194780C (nl) 1986-08-07 1987-08-06 Oraal therapeutisch systeem voor toediening van een anticonvulsivum.

Country Status (30)

Country Link
US (1) US4857336A (nl)
JP (1) JP2592460B2 (nl)
KR (1) KR950006219B1 (nl)
AT (1) AT397344B (nl)
AU (1) AU597403B2 (nl)
BE (1) BE1000235A3 (nl)
CA (1) CA1302267C (nl)
CH (1) CH668187A5 (nl)
DD (1) DD285718A5 (nl)
DE (1) DE3725824C2 (nl)
DK (1) DK175497B1 (nl)
ES (1) ES2007100A6 (nl)
FI (1) FI86143C (nl)
FR (1) FR2602425B1 (nl)
GB (1) GB2193632B (nl)
GR (1) GR871234B (nl)
HK (1) HK33793A (nl)
HU (1) HU206978B (nl)
IE (1) IE59718B1 (nl)
IL (1) IL83386A (nl)
IT (1) IT1215618B (nl)
LU (1) LU86966A1 (nl)
MY (1) MY100767A (nl)
NL (1) NL194780C (nl)
NO (1) NO173726C (nl)
NZ (1) NZ221347A (nl)
PH (1) PH25090A (nl)
PT (1) PT85489B (nl)
SE (1) SE502590C2 (nl)
ZA (1) ZA875804B (nl)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0277092B1 (de) * 1987-01-14 1992-01-29 Ciba-Geigy Ag Therapeutisches System für schwerlösliche Wirkstoffe
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
NZ226179A (en) * 1987-09-24 1991-04-26 Merck & Co Inc Controlled porosity osmotic pump for sustained release of pharmaceutical agents
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
ATE171838T1 (de) * 1991-01-16 1998-10-15 Fmc Corp Träger für wirkstoffe und damit hergestellte feste darreichungsformen
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
ATE195252T1 (de) * 1993-04-23 2000-08-15 Novartis Erfind Verwalt Gmbh Wirkstoffabgabevorrichtung mit gesteuerter freigabe
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US20040191314A1 (en) * 1994-04-28 2004-09-30 Frank Jao Antiepileptic dosage form and process for protecting antiepileptic drug
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
US6296873B1 (en) 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
CZ293062B6 (cs) 1997-09-25 2004-01-14 Bayer Aktiengesellschaft Léčivo s regulovaným uvolněním aktivní sloučeniny
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
DE69923675T2 (de) * 1998-04-29 2006-05-11 Virotex Corp., Fort Collins Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
US6706283B1 (en) 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
US7964216B2 (en) * 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
IN190699B (nl) * 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
ES2373873T3 (es) * 2001-04-10 2012-02-09 Sun Pharma Advanced Research Company Limited Composición de liberación por impulso temporizado.
US20030175346A1 (en) * 2002-02-01 2003-09-18 Anne Billotte Osmotic delivery system
US20030161882A1 (en) * 2002-02-01 2003-08-28 Waterman Kenneth C. Osmotic delivery system
US6572889B1 (en) 2002-03-07 2003-06-03 Noveon Ip Holdings Corp. Controlled release solid dosage carbamazepine formulations
WO2003075830A2 (en) * 2002-03-14 2003-09-18 Sun Pharmaceutical Industries Limited Oral controlled drug delivery system containing carbamazepine
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
RU2007143556A (ru) * 2005-04-25 2009-06-10 ТЕВА ФАРМАСЬЮТИКАЛЗ ЮЭсЭй, ИНК. (US) Композиции с пролонгированным высвобождением
US20070071819A1 (en) * 2005-05-30 2007-03-29 Kesarwani Amit K Multiple unit modified release compositions of carbamazepine and process for their preparation
MX2009000745A (es) 2006-07-21 2009-04-16 Biodelivery Sciences Int Inc Dispositivos de suministro transmucosa con admision mejorada.
US20090143362A1 (en) * 2007-12-04 2009-06-04 Barabde Umesh Vinayakrao Carbamazepine formulations
EP2231169B1 (en) * 2007-12-06 2016-05-04 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
SG10201610097WA (en) 2011-08-18 2017-01-27 Biodelivery Sciences Int Inc Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4431641A (en) * 1980-10-17 1984-02-14 Ciba-Geigy Corporation Pharmaceutical compositions having antiepileptic and antineuralgic action
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US4553973A (en) * 1982-07-12 1985-11-19 Alza Corporation Process for preparing osmotic device
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
US4716031A (en) * 1984-03-21 1987-12-29 Alza Corporation Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
US4685918A (en) * 1985-02-01 1987-08-11 Merck & Co., Inc. Lipid osmotic pump

Also Published As

Publication number Publication date
FR2602425B1 (fr) 1990-09-14
AU597403B2 (en) 1990-05-31
NO173726C (no) 1994-01-26
ATA199387A (de) 1993-08-15
IL83386A (en) 1992-01-15
GB2193632A (en) 1988-02-17
LU86966A1 (fr) 1989-03-08
DK410787D0 (da) 1987-08-06
ES2007100A6 (es) 1989-06-01
GB2193632B (en) 1990-04-25
SE502590C2 (sv) 1995-11-20
GR871234B (en) 1987-12-08
DK410787A (da) 1988-02-08
AT397344B (de) 1994-03-25
NL194780C (nl) 2003-03-04
NZ221347A (en) 1989-12-21
IE59718B1 (en) 1994-03-23
GB8717643D0 (en) 1987-09-03
SE8703034L (sv) 1988-02-08
IL83386A0 (en) 1987-12-31
FI873409A0 (fi) 1987-08-05
AU7661787A (en) 1988-02-11
NO873298L (no) 1988-02-08
KR950006219B1 (ko) 1995-06-12
ZA875804B (en) 1988-02-08
HUT44930A (en) 1988-05-30
NO873298D0 (no) 1987-08-06
CA1302267C (en) 1992-06-02
BE1000235A3 (fr) 1988-09-20
CH668187A5 (de) 1988-12-15
IT8748270A0 (it) 1987-08-05
HK33793A (en) 1993-04-16
FI873409A (fi) 1988-02-08
NO173726B (no) 1993-10-18
HU206978B (en) 1993-03-01
DD285718A5 (de) 1991-01-03
JPS6344525A (ja) 1988-02-25
IT1215618B (it) 1990-02-22
FI86143C (fi) 1992-07-27
DE3725824C2 (de) 1998-12-17
DK175497B1 (da) 2004-11-15
JP2592460B2 (ja) 1997-03-19
PT85489A (en) 1987-09-01
IE872110L (en) 1988-02-07
MY100767A (en) 1991-02-14
DE3725824A1 (de) 1988-02-11
FR2602425A1 (fr) 1988-02-12
NL8701857A (nl) 1988-03-01
SE8703034D0 (sv) 1987-08-03
FI86143B (fi) 1992-04-15
PT85489B (pt) 1990-06-29
PH25090A (en) 1991-02-19
KR880002511A (ko) 1988-05-09
US4857336A (en) 1989-08-15

Similar Documents

Publication Publication Date Title
NL194780B (nl) Oraal therapeutisch systeem voor toediening van een anticonvulsivum.
DE3680943D1 (de) Therapeutische mittel zur oralen verabreichung.
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
DE3771272D1 (de) Pulsierendes arzneistoffabgabesystem.
NO871790L (no) Fremgangsmaate for fremstilling av et oralt farmasoeytisk preparat.
MX9203816A (es) Sistema de administracion farmaceutica.
DK257485D0 (da) Farmaceutiske praeparater til oral indgift
IT8322832A0 (it) Dispositivo per la somministrazione controllata di farmaci.
IT8521922A0 (it) Sistema di somministrazione di farmaci.
DZ1078A1 (fr) Formulation pharmaceutiques de substance labiles aux acides pour administration orale.
IT8667332A0 (it) Dispositivo per l erogazione ddi farmaci
NL193218B (nl) Werkwijze voor de bereiding van roestvrij staal.
DE3883484D1 (de) Medizinisches Ultraschallabbildungssystem.
NL970023I1 (nl) Medicamenten voor behandeling van oogontsteking.
NO882897D0 (no) Avleveringssystem for legemidler.
ES2022454B3 (es) Sistema terapeutico para la liberacion controlada de drogas.
DK528988D0 (da) Laegemiddelafgivelsessystem
FI875098A0 (fi) Transdermalt terapeutiskt system.
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
NO865028D0 (no) Fremgangsmaate for fremstilling av et terapeutisk system.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
IT8620803A0 (it) Sistemi terapeutico per la cessione controllata di farmaci.
NL193441B (nl) Farmaceutisch preparaat voor veterinair gebruik.
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
ATA264087A (de) Pharmazeutische praeparate zur oralen verabreichung

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: NOVARTIS AG

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20070806